The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...
The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...
(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...
Medical Device Network on MSN
HeartBeam reports positive ECG data in heart attack detection
HeartBeam said its study data advances the scientific foundation supporting a planned indication expansion of its ECG device ...
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results